Voyager Therapeutics Inc VYGR:NASDAQ

Last Price$2.83NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/21/22

Today's Change-0.07(2.41%)
Bid (Size)$2.79 (75)
Ask (Size)$2.98 (2)
Day Low / High$2.83 - 3.00
Volume504.0 K

View Biotechnology IndustryPeer Comparison as of 01/21/2022


Voyager Therapeutics Inc ( NASDAQ )

Price: $2.83
Change: -0.07 (2.41%)
Volume: 504.0 K
4:00PM ET 1/21/2022

Concert Pharmaceuticals Inc ( NASDAQ )

Price: $3.11
Change: +0.05 (1.63%)
Volume: 122.8 K
4:00PM ET 1/21/2022

Champions Oncology Inc ( NASDAQ )

Price: $7.98
Change: +0.01 (0.13%)
Volume: 10.9 K
3:59PM ET 1/21/2022

Infinity Pharmaceuticals Inc ( NASDAQ )

Price: $1.22
Change: -0.06 (4.69%)
Volume: 1.5 M
4:00PM ET 1/21/2022

MediciNova Inc ( NASDAQ )

Price: $2.22
Change: -0.12 (5.13%)
Volume: 133.5 K
4:00PM ET 1/21/2022

Read more news Recent News

Verve Therapeutics Names Allison Dorval as Finance Chief
9:32AM ET 11/29/2021 MT Newswires

Verve Therapeutics (VERV) on Monday said that Allison Dorval has been named as chief financial officer. Dorval joins Verve from Voyager Therapeutics...

--Chardan Adjusts Price Target on Voyager Therapeutics to $4 From $5.50 While Awaiting Info on New Pipeline, Maintains Neutral Rating
12:43PM ET 11/03/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Voyager Therapeutics Says Preclinical Data Supports GBA1 Gene Therapy
1:32PM ET 10/20/2021 MT Newswires

Voyager Therapeutics (VYGR) said Wednesday preclinical data showed a single intravenous dose of its GBA1 gene replacement therapy achieved widespread...

Voyager Therapeutics Stock Drops 14%, Trading Volume at Over Thrice the Daily Average
2:53PM ET 10/11/2021 MT Newswires

Voyager Therapeutics (VYGR) shares slumps 14% in afternoon trade, trading at volumes thrice the daily average. The sell-off comes after the company...

View all Commentary and Analysis

Genomic Medicine 2021: (Happy To) Turn The Page
9:33PM ET 1/04/2022 Seeking Alpha

Voyager Therapeutics: Another Year, Another Deal
11:27AM ET 11/21/2021 Seeking Alpha

Wall Street Breakfast: What Moved Markets
8:00AM ET 10/09/2021 Seeking Alpha

Voyager Therapeutics (VYGR) Investor Presentation - Slideshow
3:05PM ET 9/20/2021 Seeking Alpha

Company Profile

Business DescriptionVoyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA. View company web site for more details
Address75 Sidney Street
Cambridge, Massachusetts 02139
Number of Employees123
Recent SEC Filing01/18/20224
Chairman, President & Chief Executive OfficerMichael J. Higgins
Chief Scientific Officer & DirectorGlenn F. Pierce
Senior Vice President & General CounselRobert W. Hesslein
Vice President-FinanceJulie Burek

Company Highlights

Price Open$2.90
Previous Close$2.90
52 Week Range$2.46 - 9.10
Market Capitalization$107.4 M
Shares Outstanding38.0 M
SectorHealth Technology
Next Earnings Announcement02/24/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.43
Beta vs. S&P 500N/A
Revenue$7.6 M
Net Profit Margin-584.69%
Return on Equity-76.02%

Analyst Ratings as of 12/31/2021

Consensus RecommendationConsensus Icon
Powered by Factset